← Back

Contec Medical Systems Co Ltd

Contec Medical Systems Co., Ltd. researches, develops, produces, and sells medical diagnostic and monitoring equipment, as well as digital healthcare services, in China and internationally. Its product range includes electronic sphygmomanometers, ambulatory blood pressure monitors, pulse oximeters, patient monitors, stethoscopes, simulators, multi-parameter vital signs monitors, central monitoring systems, electrocardiograph products, endoscopes, fetal dopplers and monitors, ultrasound diagnostic systems, analyzers, infusion pumps, brain electric activity mapping and EMG/EP systems, nebulizers, spirometers, blood glucose and uric acid meters, oxygen concentrators, capnographs, and airway pressure devices. The company also offers infusion and syringe pumps, massagers, sleep and snoring aids, thermometers, telemedicine and veterinary products, dispensing appliances, electronic colposcopes, and accessories, and is involved in the import and export, trade, consulting, and customer service of medical equipment, marketing activities, molds, and bio-based materials and dental products. Founded in 1996 and headquartered in Qinhuangdao, China, it sells its products through distributors.

Country
Price · split & dividend adjusted
News & notes moving 300869.CS
300869.CS

Contec Medical Systems Receives Medical Device Registration Certificates for Two Fetal Monitors

Contec Medical Systems Company Limited announced on September 14 that it has recently obtained two Medical Device Registration Certificates issued by the Hebei Medical Products Administration. The registration certificate number for the ultrasound Doppler fetal monitor is Ji Xie Zhu Zhun 20262180265, with model specifications CMS800K and CMS800KS, primarily used for continuous monitoring of fetal heart rate, fetal movement, and maternal uterine contraction pressure during the perinatal period. The registration certificate number for the fetal and maternal multi-parameter monitor is Ji Xie Zhu Zhun 20262070264, with model specifications CMS800C and CMS800C-PLUS, for monitoring maternal electrocardiogram, non-invasive blood pressure, heart rate, blood oxygen saturation, body temperature, respiration, uterine contraction pressure, as well as fetal heart rate and fetal movement. Both registration certificates are valid from September 8, 2026 to September 7, 2031. The company stated that the first-time acquisition of these product registration certificates is conducive to enriching its product line and enhancing core competitiveness, and has a positive impact on the company's development. However, actual future sales of the products will depend on market promotion results and actual demand, and the impact on future operating revenue cannot yet be accurately predicted.
Jiemian·5dRead more →
300869.CS2

Contec Medical Systems reports net loss of 49.27 million yuan in 2026 interim results, swinging from profit to loss

Contec Medical Systems released its 2026 interim report, showing total operating revenue of 226 million yuan and a net loss attributable to the parent company of 49.27 million yuan, swinging from profit to loss. This represents a decrease of 66.21 million yuan compared with the same period last year, down 390.88 percent year on year. Net cash inflow from operating activities was 33.44 million yuan. The company's asset-liability ratio was 36.24 percent, gross margin was 48.45 percent, return on equity was negative 2.93 percent, and diluted earnings per share was negative 0.12 yuan. The number of shareholders was 29,700, and the top ten shareholders held 52.34 percent of the total share capital.
Jiemian·22dRead more →
300869.CS3

Contec Medical Systems Receives Medical Device Registration Certificate for Bi-Level Positive Airway Pressure Therapy Device

Contec Medical Systems (Qinhuangdao) Co., Ltd. has recently obtained a medical device registration certificate from the Hebei Medical Products Administration for its bi-level positive airway pressure therapy device, model R100BP. The certificate number is 冀械注准20262080182, valid until July 1, 2031. The device is used to alleviate snoring, hypopnea, and sleep apnea during sleep in patients weighing over 30 kilograms, and is suitable for use in homes, clinics, and hospitals. Meanwhile, the company completed registration certificate changes for three products: the medical infrared thermometer reduced model TP550 and changed its structure, composition, and technical requirements; the infusion pump added model SP770 and changed technical requirements and scope of application, explicitly stating it is not for infusion of blood products, analgesic drugs, chemotherapy drugs, or insulin; and the blood oxygen and ECG device data management software changed its structure, composition, and technical requirements. The company stated that the new registration certificate will enrich its product line and the changes will optimize product performance, but the specific impact on sales cannot yet be predicted.
Jiemian·68dRead more →